| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.082 | 0.08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.042 | 0.3 |